Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

5.83
Delayed Data
As of 3:02pm ET
 +0.11 / +1.92%
Today’s Change
4.76
Today|||52-Week Range
8.24
-2.02%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close5.72
Today’s open5.51
Day’s range5.51 - 5.83
Volume3,289
Average volume (3 months)12,721
Market cap$27.7M
Dividend yield--
Data as of 3:02pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio29.2
Price/Sales2.70
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
KDUSCadus Corp-0.02-2.02%
COOLPolarityte Inc-0.33-4.87%
HSGXHistogenics Corp-0.01-0.60%
PTIEPain Therapeutics In...+0.01+2.04%
Data as of 3:45pm ET, 02/27/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.0K
Net profit margin5.32%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts


Search for Jobs